Workflow
vaccine safety
icon
Search documents
FDA commissioner Dr. Marty Makary on vaccine safety and recommendations
CNBC Television· 2025-07-11 12:25
Our newsmaker this hour, Dr. . Marty McCary, the FDA commissioner, marking his first 100 days on the job. It's been a busy few months with many changes at the agency from vaccines to staffing.Good morning, uh, doctor. Good morning, Joe. I don't maybe you've been on a few time.I don't I I don't remember, but we all went through uh that that period together, obviously, and and there's a lot of u of of a look back now at at at that period. you know, it's, you know, it's a it's a hot button issue and sometimes ...
Vaccine expert warns ‘science denialists’ now ‘making policy’ after RFK Jr. shakes up vaccine panel
NBC News· 2025-07-03 22:01
Health and Human Services Secretary Robert F. Kennedy Jr. ., a longtime peddler of misinformation surrounding vaccine safety, has been moving to reshape US vaccine policy, raising alarm within much of the medical community.According to new reports, the FDA's top vaccine official moved last month to limit the use of two COVID vaccines that had been approved, overruling recommendations by agency medical experts who plan to approve the shots for everyone 12 and older. It all comes after the new members of the ...
New vaccine panel meeting underway
CNBC Television· 2025-06-26 15:46
Welcome back. Despite the market nearing new highs here, the healthc care sector is one of the few groups still negative on the year. Also the second worst performer for Q2, just behind energy.UNH, United Healthcare biggest drag on the sector down 42% since the start of April. David. All right.Meanwhile, RFK's new handpicked vaccine advisory committee voting on the RSV vaccine this morning and the flu shot this afternoon. Angelica Peoples has the latest for us. Angelica.Hey, David. That's right. So, in its ...
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
CNBC· 2025-03-31 14:13
Shares of Moderna and Novavax dropped more than 11% and 6%, respectively, in early trading. Meanwhile, the SPDR S&P Biotech ETF slid nearly 5%. Shares of Pfizer , which has broader businesses to insulate it from damage to its vaccine portfolio, lost about 2%. The departure of Peter Marks, the Food and Drug Administration's top vaccine regulator, has raised fresh fears about whether the Trump administration will quickly approve and promote critical shots. In his position, Marks oversaw the introduction of Co ...